Schizophrenia Treatment in Palm Beach
Advanced psychopharmacology and psychiatric management for schizophrenia spectrum disorders
Understanding Schizophrenia
Schizophrenia is a serious mental illness characterized by distortions in thinking, perception, emotions, language, sense of self, and behavior. Positive symptoms include hallucinations (hearing voices is most common), delusions (false beliefs held with conviction), and disorganized thinking. Negative symptoms — flat affect, avolition, alogia, anhedonia — are often more disabling long-term and more treatment-resistant.
Schizophrenia typically emerges in late adolescence to early adulthood. Early intervention with appropriate antipsychotic medication significantly improves long-term outcomes. Dr. Agresti specializes in complex psychopharmacology — selecting and optimizing antipsychotic regimens for patients who have not responded to standard treatments.
Signs & Symptoms
Positive Symptoms
- Auditory, visual, or tactile hallucinations
- Delusions (persecutory, grandiose, referential)
- Disorganized speech and thought
- Grossly disorganized or catatonic behavior
Negative Symptoms
- Diminished emotional expression (flat affect)
- Avolition — reduced motivation to initiate activity
- Alogia — poverty of speech
- Anhedonia — inability to experience pleasure
- Cognitive impairment — working memory, processing speed, executive function
- Social withdrawal and impaired functioning
- Lack of insight into illness (anosognosia) — often driving medication non-adherence
Treatment Approaches
Antipsychotic medication is the cornerstone of schizophrenia treatment. Second-generation (atypical) antipsychotics — risperidone, olanzapine, quetiapine, aripiprazole, lurasidone, ziprasidone, brexpiprazole, cariprazine — are first-line. Clozapine remains the most effective antipsychotic for treatment-resistant schizophrenia and is underutilized due to monitoring requirements. Long-acting injectable antipsychotics (LAIs) dramatically improve adherence and reduce relapse.
Psychosocial interventions — supported employment, family therapy, cognitive remediation, and Assertive Community Treatment — are essential complements to medication. Dr. Agresti focuses on the psychopharmacology component, working collaboratively with the patient's support system and other providers.
Complex Psychopharmacology Expertise
Managing schizophrenia often requires navigating medication failures, side effects, and complex drug interactions. With 30+ years of psychiatric experience, Dr. Agresti brings sophisticated clinical judgment to treatment-resistant presentations. His concierge model ensures your care is never rushed — every appointment is as long as it needs to be.
Complex PsychopharmacologyFrequently Asked Questions
Clozapine is recommended when a patient has not responded adequately to at least two trials of other antipsychotic medications, a condition known as treatment-resistant schizophrenia. It remains the most effective antipsychotic available and is significantly underutilized. Dr. Agresti has extensive experience initiating and managing clozapine, including the required blood monitoring protocol.
Long-acting injectable antipsychotics (LAIs) are medications administered every 2 to 12 weeks by injection, eliminating the need for daily oral pills. They are especially beneficial for patients who struggle with medication adherence, which is a leading cause of relapse in schizophrenia. LAIs dramatically reduce hospitalization rates and provide more stable symptom control.
Yes, many people with schizophrenia live independently and maintain employment with proper treatment. The key factors are consistent antipsychotic medication, early intervention, and a strong support system. Dr. Agresti's concierge model provides the level of ongoing psychiatric access that supports long-term stability and functional recovery.
Metabolic side effects are a significant concern with many antipsychotics, particularly olanzapine and clozapine. Management includes selecting medications with lower metabolic risk when possible, regular monitoring of weight, glucose, and lipids, and proactive interventions. With 30+ years of complex psychopharmacology experience, Dr. Agresti carefully balances efficacy against side effect burden for each patient.
Schizophrenia primarily involves psychotic symptoms like hallucinations and delusions, while schizoaffective disorder includes those same psychotic symptoms plus a prominent mood component — either depression or bipolar-type mood episodes. The distinction matters because schizoaffective disorder requires treatment of both the psychotic and mood symptoms simultaneously. Learn more about schizoaffective disorder and its unique treatment approach.